MMSI — Stock Film
STOCK FILMSCENE 1/11MMSI · $75.17
Stock Expert AI presents
MMSI
Merit Medical Systems, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Merit Medical Systems, Inc. A quick introduction.

On the stock market since 1990, it operates in the world of health and science. It has 7,500 employees. Now — the numbers.

on the stock market since 1990
7,500 employees
$4.5B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $8 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 8%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
95%Cardiovascular
Cardiovascular 95%Endoscopy 5%
95% of all revenue comes from a single line: Cardiovascular.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales are growing, year after year.

Average growth of 9% a year over the last 4 years. Every year shown ended in profit.

$1.1B
2021
$1.2B
2022
$1.3B
2023
$1.4B
2024
$1.5B
2025
INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
84
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
62
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
76
strong

Clearly above the class average — a step short of the very top.

GROWTH
86
very strong

Sales are growing strongly for its sector.

PRICE MOMENTUM
56
average

The price is looking for direction — no strong breakout, no collapse.

No real weak spot in any of the five subjects — a balanced report card.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking8/10
WEAK SPOTS
The stock has lost its spark0/10
THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 32% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 10% a year on average.

2
THE BRIGHT SIDE · 2/3
Delivers on expectations

It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.

3
THE BRIGHT SIDE · 3/3
Executives are buying their own stock

Over the last 12 months, company executives reported 37 buys and 22 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/2
A rich price tag

The company’s market value is 35 times its annual profit. Even a small disappointment could hit the price hard.

2
THE RISKS · 2/2
The stock has lost its spark

Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.

FINALE · THE GRADE
A
0 / 100 · MoonshotScore

On our five-subject report card, MMSI sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: MMSI is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film